Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Tugwell

Showing results (261-270 of 301) with videos related to

Pageof 31
Sort By:
The Journal of Rheumatology|July 1, 1992
Physical disability among Canadians reporting musculoskeletal diseasesD L Reynolds, L W Chambers, E M Badley, et al.
Patient Education and Counseling|September 10, 1998
A decision aid for women considering hormone therapy after menopause: decision support framework and evaluationA M O'Connor, P Tugwell, G A Wells, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|July 29, 1998
Randomized trial of a portable, self-administered decision aid for postmenopausal women considering long-term preventive hormone therapyA M O'Connor, P Tugwell, G A Wells, et al.
Medical Education|September 1, 1989
Setting educational priorities for learning the concepts of population healthP J MacDonald, J P Chong, P Chongtrakul, et al.
Annals of the Rheumatic Diseases|November 27, 2004
Evaluation of WOMAC 20, 50, 70 response criteria in patients treated with hylan G-F 20 for knee osteoarthritisN Bellamy, M J Bell, C H Goldsmith, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|December 7, 2007
Direct costs of osteoporosis and hip fracture: an analysis for the Mexican healthcare systemP Clark, F Carlos, C Barrera, et al.
The Journal of Rheumatology|May 22, 2001
Patient based method of assessing adverse events in clinical trials in rheumatology: the revised Stanford Toxicity IndexV Welch, G Singh, V Strand, et al.
The Cochrane Database of Systematic Reviews|October 30, 2003
Risedronate for the prevention and treatment of postmenopausal osteoporosisA Cranney, L Waldegger, N Zytaruk, et al.
The Journal of Rheumatology|December 1, 1987
Low dose cyclosporine in rheumatoid arthritis: a pilot studyP Tugwell, C Bombardier, M Gent, et al.
The Journal of Rheumatology|June 1, 1997
Osteoporosis clinical trials endpoints: candidate variables and clinimetric propertiesA Cranney, P Tugwell, S Cummings, et al.
Pageof 31

Showing results (261-270 of 301) with videos related to

Sort By:
Pageof 31
The Journal of Rheumatology|July 1, 1992
Physical disability among Canadians reporting musculoskeletal diseasesD L Reynolds, L W Chambers, E M Badley, et al.
Patient Education and Counseling|September 10, 1998
A decision aid for women considering hormone therapy after menopause: decision support framework and evaluationA M O'Connor, P Tugwell, G A Wells, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|July 29, 1998
Randomized trial of a portable, self-administered decision aid for postmenopausal women considering long-term preventive hormone therapyA M O'Connor, P Tugwell, G A Wells, et al.
Medical Education|September 1, 1989
Setting educational priorities for learning the concepts of population healthP J MacDonald, J P Chong, P Chongtrakul, et al.
Annals of the Rheumatic Diseases|November 27, 2004
Evaluation of WOMAC 20, 50, 70 response criteria in patients treated with hylan G-F 20 for knee osteoarthritisN Bellamy, M J Bell, C H Goldsmith, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|December 7, 2007
Direct costs of osteoporosis and hip fracture: an analysis for the Mexican healthcare systemP Clark, F Carlos, C Barrera, et al.
The Journal of Rheumatology|May 22, 2001
Patient based method of assessing adverse events in clinical trials in rheumatology: the revised Stanford Toxicity IndexV Welch, G Singh, V Strand, et al.
The Cochrane Database of Systematic Reviews|October 30, 2003
Risedronate for the prevention and treatment of postmenopausal osteoporosisA Cranney, L Waldegger, N Zytaruk, et al.
The Journal of Rheumatology|December 1, 1987
Low dose cyclosporine in rheumatoid arthritis: a pilot studyP Tugwell, C Bombardier, M Gent, et al.
The Journal of Rheumatology|June 1, 1997
Osteoporosis clinical trials endpoints: candidate variables and clinimetric propertiesA Cranney, P Tugwell, S Cummings, et al.
Pageof 31